Content continues after advertisement

Breed-Specific Anesthesia

Stephanie Krein, DVM, & Lois A. Wetmore, DVM, ScD, DACVA Tufts University

Anesthesiology & Pain Management

March 2012
Peer Reviewed

Sign in to Print/View PDF

Genetic differences and anatomic factors can contribute to variability and complications during anesthetic events.

Certain breed differences can lead to greater risks for airway obstruction, increased responsiveness to anesthetic drugs, and delayed recovery, all of which can result in increased anesthesia-related morbidity and mortality. Individual genetic variability can trigger unexpected and adverse responses to anesthetic drugs, which need to be identified by good recordkeeping and consistent patient monitoring. Although genetic differences are typically held responsible for prolonged recoveries and increased drug responsiveness, true genetic sensitivity has been demonstrated in only a handful of breeds, including the greyhound and the collie.

Because many canine breeds can suffer from cardiac disease, both acquired and congenital, it is important to know which patients are likely to be affected before the anesthetic protocol is planned. If cardiac disease is suspected, a full cardiac workup with a veterinary cardiologist is recommended.

See a checklist of Anesthetic-Related Problems by Breed

Brachycephalic Breeds

Clinician's Brief

Brachycephalic breeds have anatomic considerations that may affect anesthetic outcome. Most brachycephalic breeds suffer from brachycephalic airway syndrome (BAS), which is characterized by stenotic nares, elongated soft palate, everted laryngeal saccules, and hypoplastic trachea.

Many brachycephalic dogs respond well to acepromazine in conjunction with an opioid; however, the sedative dose should be half of that used for nonbrachycephalic dogs. Full mu-opioid agonists can be used but because they may cause excessive respiratory depression, a reversal agent should be available. Dexmedetomidine should be avoided because of the presence of high vagal tone in these breeds. Anticholinergics, such as glycopyrrolate, may be used to decrease airway secretions and counteract high vagal tone.Affected dogs have narrower upper airways than do dogs with normal anatomic features.1-3 Because in brachycephalic breeds additional airway contraction can occur with stress (ie, increased respiratory effort, turbulent flow), clinicians need to be prepared for possible upper airway obstruction. Furthermore, brachycephalic dogs must be monitored closely after premedication, throughout anesthesia and the postoperative period, and after extubation. An oxygen source and endotracheal tube should be readily available.

Preoxygenation is recommended before dogs with BAS are induced.2-4 Propofol or a similar short-acting drug should be used for induction and intubation should be completed as rapidly as possible. Mask inductions should be avoided,3,4 and smaller endotracheal tubes should be used.

Because brachycephalic breeds tend toward obesity, controlled or mechanical ventilation is often necessary. Most problems associated with mechanical ventilation occur during induction and recovery, so monitoring is particularly important.

Extubation should be postponed until the patient is bright, alert, swallowing—even chewing on the endotracheal tube.4 If extubation is attempted while the patient is sedated and groggy from anesthesia, there is increased risk for upper airway obstruction. If upper airway obstruction occurs, the patient should be reintubated.

Brachycephalic cats should be handled with care from premedication to recovery and treated in a manner similar to dogs.

Related Article: Anesthetic Options for Short-Duration Procedures

Clinician's Brief

Most breeds do not have true sensitivities to anesthestics, although sighthounds (particularly the greyhound) do have genetic factors that cause them to metabolize drugs differently. Therefore, before designing an anesthetic protocol, examination findings and blood work results need to be evaluated. Sighthounds have a higher packed cell volume and lower serum albumin concentration than do mixed breeds.2,3 Sighthounds also should be evaluated for cardiac abnormalities (eg, dilated cardiomyopathy).

Because sighthounds are high-energy animals, they may experience high levels of hospitalization stress. Acepromazine is recommended for preventing stress in healthy sighthounds, but some individuals may be more sensitive to its sedative effects, so a lower dose (0.02–0.03 mg/kg) is advised.4,5 In addition, sighthounds metabolize drugs more slowly as compared with the average dog. Thiobarbiturates should be avoided and other induction agents (eg, propofol, ketamine, etomidate) used instead.1-3 Of note, propofol is metabolized more slowly in these dogs because of reduced hepatic enzymatic activity, which may result in slower recovery.4,6,7

Sighthounds have a low percentage of body fat (17%) compared with the average dog (35%),6 which leaves them at risk for hypothermia during anesthetic procedures.2,3,6 Therefore, it is important to use hot water blankets and forced-air warmers during the perioperative period.

Herding Breeds
Clinician's Brief

The effect of certain anesthetic drugs on herding dogs (eg, collie, border collie, Australian shepherd, Shetland sheepdog) is somewhat controversial. However, these breeds have a high prevalence (eg, up to 75% in collies in the United States) for genetic mutation in the ABCB1 (formerly MDR1) gene.8,9 ABCB1 encodes P-glycoprotein, an adenosine triphosphate–driven pump that is an integral component of the blood–brain barrier and provides protection from toxic drug accumulation in body fluids, such as cerebrospinal fluid (CSF).10 In the collie and other herding breeds, this genetic mutation results in a defective pump that allows a select group of drugs to accumulate within the brain.

Acepromazine and opioids, particularly butorphanol,9 are members of this drug group, and their accumulation in CSF may cause marked sedation and respiratory depression. When using these agents in susceptible breeds, the dose should be decreased by 25% and patients closely monitored for side effects.5,9

Related Article: Anesthesia Monitoring: Raising the Standards of Care

Toy Breeds
Clinician's Brief

Because of their size, toy breeds can present unique challenges. Obtaining an accurate weight and using the appropriate dose of anesthetic drug are essential. Monitoring during surgery likewise is important. In small patients, Doppler blood pressure measurement has been more accurate than oscillometric monitoring; in addition, it provides an auditory sound to monitor heart rate and rhythm.

Toy breeds have a greater body surface area–to–body mass ratio and higher metabolic rate, which can lead to lower body temperatures and hypoglycemia.1 It is important to support normal body temperature during anesthesia, monitor blood glucose levels, and apply adequate supplementation as indicated.3

Giant Breeds
Clinician's Brief

Giant breeds often respond profoundly to normal therapeutic doses of sedatives, such as acepromazine. In this patient population, it is important to either reduce the dose of acepromazine (0.01–0.025 mg/kg) or calculate the dose based on lean body mass or surface area and not the actual body weight.2,3  


Doberman Pinscher
Clinician's Brief

Genetic variation is also noted in Doberman pinschers. In addition to a predilection for developing dilated cardio­myopathy, these dogs can have von Willebrand disease, which impairs normal clotting. It is important to evaluate the coagulation status of these patients before surgery.

If von Willebrand disease is suspected, desmopressin (also known as DDAVP) given before surgery promotes von Willebrand factor secretion from endothelial storage sites.3

In this patient population, the use of NSAIDs is somewhat controversial and other analgesic options should be explored. If NSAIDs must be administered, preference should be given to cyclooxygenase (COX)-2–selective drugs.

Boxers of UK Lineage
Clinician's Brief

On rare occasions, individual variability can result in a subpopulation within a breed that responds differently to anesthetics. An example can be seen in boxers from the UK. In this subpopulation, acepromazine often causes severe bradycardia, hypotension, and collapse, so a reduced dose of acepromazine (0.01–0.025 mg/kg) is recommended.2,4

Because there are no published reports describing similar effects in US-bred boxers, standard doses of acepromazine are typically routine in the US subpopulation.

Closing Remarks

Although it is important to be aware of breed-related anesthetic differences, the primary consideration is the individual patient and tailoring the anesthetic protocol accordingly. With proper perioperative workup and appropriate patient monitoring, safe and successful sedation and anesthesia can be performed in any breed of dog or cat. Patient monitoring should begin with premedication and end only after the patient has been extubated and is normothermic, stable, and alert.

STEPHANIE KREIN, DVM, is an anesthesia resident at Tufts Cummings University School of Veterinary Medicine, where her primary focus includes cardiovascular and respiratory physiology in both small and large animals. Prior to becoming an anesthesia resident, she practiced as an emergency veterinarian near Cape Cod, Massachusetts.

LOIS A. WETMORE, DVM, ScD, DACVA, is an assistant professor in the department of clinical sciences at Tufts Cummings University School of Veterinary Medicine, where her focus is anesthesiology and pain management. Her research interests include polymorphisms in opioid receptors, the effects of MDR1 mutations on oral morphine absorptions, and the metabolism of NSAIDs in dogs. Dr. Wetmore received her DVM from Colorado State University and ScD from Harvard School of Public Health.


For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2022 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy